Michael Celano - 17 Jan 2024 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Chief Financial Officer
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
17 Jan 2024
Net transactions value
$0
Form type
4
Filing time
19 Jan 2024, 16:32:58 UTC
Previous filing
18 May 2023
Next filing
24 Jan 2025
SEC
View on sec.gov

Key filing fact

Michael Celano filed Form 4 for Larimar Therapeutics, Inc. (LRMR) on 19 Jan 2024.

Key facts

  • This page summarizes Michael Celano's Form 4 filing for Larimar Therapeutics, Inc. (LRMR).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 19 Jan 2024, 16:32.

Change

  • Previous filing in this sequence was filed on 18 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

LRMR transaction

Common Stock

Award

Transaction value
$0
Shares
+31,250
Change %
+28%
Price
$0.000000
Shares after
143,996
Date
17 Jan 2024
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

LRMR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+187,500
Change %
Price
$0.000000
Shares after
187,500
Date
17 Jan 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
187,500
Exercise price
$4.21
Footnotes
F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2 The option vests 25% on January 17, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .